Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Doctor at Medical University, Varna, Bulgaria

Dr. Yoana Dyankova Dyankova is a dedicated pediatrician and clinical researcher specializing in pediatric gastroenterology, hepatology, and nutrition. She holds a PhD in Pediatrics from the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, where she also serves in the Pediatric Intensive Care Unit at St. Marina University Hospital. Her research focuses primarily on celiac disease in children, particularly its impact on bone health, as demonstrated in her dissertation and multiple peer-reviewed publications, including a recent article in Nutrients (2025). Dr. Dyankova is an active member of national pediatric and gastroenterology associations and contributes to both clinical care and academic development. Fluent in English and German, she engages with the international scientific community and remains committed to translating research into improved patient outcomes. With her growing publication record, clinical integration, and academic rigor, she stands out as a promising young researcher in the field of pediatric medicine.

Professional Profile 

Google Scholar
ORCID Profile 

Education

Dr. Yoana Dyankova Dyankova began her academic journey at the Vasil Drumev High School of Natural Sciences and Mathematics in Veliko Tarnovo, graduating in 2010. She pursued her medical degree at the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, completing it in 2016. From 2017 to 2022, she specialized in pediatrics, gaining comprehensive clinical training and board certification in the field. In 2018, she enrolled in a PhD program in Pediatrics at the same university, where she focused her research on celiac disease and its effects on pediatric bone health. She successfully defended her dissertation in 2023. Dr. Dyankova has since continued to develop professionally by pursuing further specialization in pediatric gastroenterology starting in July 2025. Her academic path demonstrates strong commitment, discipline, and a focused interest in improving pediatric healthcare through both clinical practice and rigorous scientific research.

Professional Experience

Dr. Dyankova has cultivated a balanced career combining clinical excellence and academic growth. Since January 2022, she has served as a pediatrician at the Pediatric Intensive Care Unit (PICU) of the First Children’s Clinic, St. Marina University Hospital in Varna. Her role in the PICU places her at the frontline of managing critically ill children, often requiring advanced decision-making and teamwork in high-pressure situations. Prior to this, she completed a five-year pediatric residency, gaining hands-on experience in general pediatrics. Her transition into the subspecialty of pediatric gastroenterology as of July 2025 marks a strategic shift aligned with her research interests. Parallel to her clinical duties, Dr. Dyankova was engaged in doctoral studies for five years, conducting original research and contributing to academic publications. Her dual role as both a clinician and researcher enhances her ability to apply scientific findings directly to patient care, making her a valuable asset in modern pediatric medicine.

Research Interest

Dr. Dyankova’s primary research interests lie at the intersection of pediatric gastroenterology, hepatology, and nutrition, with a concentrated focus on celiac disease (CD). Her doctoral thesis explored bone health in children with CD, addressing the metabolic and developmental complications arising from malabsorption and chronic inflammation. Beyond celiac disease, she has expressed research interest in related gastrointestinal disorders such as inflammatory bowel disease (IBD), as well as broader issues within pediatric intensive care. Her work is characterized by clinical relevance and translational value, aiming to bridge the gap between scientific research and bedside care. Publications in both national and international journals reflect her dedication to improving diagnostic and treatment protocols in children with chronic gastrointestinal conditions. Dr. Dyankova continues to build her research portfolio by participating in collaborative studies, focusing on early diagnosis, nutritional interventions, and long-term management outcomes in affected pediatric populations, ensuring a direct impact on clinical practice.

Award and Honor

While specific named awards are not listed in the biography, Dr. Yoana Dyankova Dyankova has received notable academic and professional recognition through her successful completion of a PhD and multiple scientific publications. Her research has been published in reputable journals such as Nutrients, indicating peer validation and relevance of her work. She is an active member of the National Pediatric Association and the community of Pediatric Gastroenterologists in Bulgaria, reflecting her standing in the professional community. These memberships signify not only recognition by peers but also her continued contribution to scientific discussions and advancements in pediatric healthcare. Her role in high-stakes clinical environments like the Pediatric Intensive Care Unit further demonstrates trust in her medical competence and decision-making. With growing academic output and clear specialization in a crucial field, Dr. Dyankova is well-positioned to earn future distinctions and leadership roles in pediatric research and clinical practice at both national and international levels.

Conclusion

Dr. Yoana Dyankova Dyankova exemplifies the qualities of a dedicated clinician-scientist, balancing hands-on pediatric care with high-impact academic research. With a solid foundation in pediatrics and a focused interest in gastroenterology and nutrition, she has steadily advanced her career through both clinical excellence and scholarly contribution. Her doctoral work on bone health in children with celiac disease highlights her ability to address complex, real-world health challenges through evidence-based research. Now working in a pediatric intensive care setting and continuing her subspecialty training, Dr. Dyankova is expanding her expertise and influence in critical areas of child health. Her publications, professional affiliations, and academic achievements underscore a deep commitment to the advancement of pediatric medicine. While still early in her career, her trajectory suggests strong potential for leadership in research and healthcare. She is a promising candidate for recognition such as the Best Researcher Award and is well-poised for continued professional impact.

Publications Top Notes

  1. Title: Presentation of Childhood Newly-Diagnosed Diabetes During the COVID-19 Pandemic – Is There a Change?

    • Authors: Y. Bazdarska, V. Iotova, T. Karamfilova, Y. Dyankova, T. Stefanova, …

    • Journal: Diabetes Technology & Therapeutics, Vol. 23, A202

    • Year: 2021

  1. Title: Delayed Bone Age and Osteoprotegerin Levels in Pediatric Celiac Disease: A Three-Year Case–Control Study

    • Authors: R. Pancheva, Y. Dyankova, N. Rasheva, K. Koleva, V. Iotova, M. Dzhogova, M. Fiore, M. Georgieva

    • Journal: Nutrients, Vol. 17 (14), Article 2295

    • Year: 2025

  1. Title: Macrophage Activation Syndrome After COVID-19 Infection in a Patient with Systemic Juvenile Idiopathic Arthritis

    • Authors: M. Boyadzhiev, B. Varbanova, M. Belcheva, P. Shivachev, D. Krumova, Y. Dyankova, …

    • Journal: Scripta Scientifica Medica, Vol. 55(1), pp. 27–31

    • Year: 2023

  1. Title: Bone Health in Children with Celiac Disease (PhD Dissertation)

    • Author: Y. Dyankova

    • Database: PQDT-Global (ProQuest Dissertations)

    • Year: 2022

  1. Title: New Developments in the Diagnostics of Celiac Disease in Children

    • Authors: Y. Dyankova, M. Georgieva, N. Rasheva, K. Koleva

    • Journal: Journal of the Union of Scientists-Varna. Medicine and Ecology Series, Vol. 24(1)

    • Year: 2019

  1. Title: Bacterial Pulmonary Colonization with Pseudomonas aeruginosa in Cystic Fibrosis Patients

    • Authors: M. Nikolova, Y. Dyankova, I. Hristov, M. Georgieva

    • Journal: Izvestia Journal of the Union of Scientists-Varna. Medicine and Ecology Series

    • Year: 2019

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Senior Consultant at Department of Oral and Maxillofacial Surgery / Plastic surgery, University Medicine Lübeck, Germany

Dr. med. Christian Seebauer, MD, DDS, is a distinguished clinician-scientist with dual qualifications in medicine and dentistry and board certifications in Oral and Maxillofacial Surgery and Oral Surgery. Currently a Senior Consultant at University Medical Center Lübeck, he has held several leadership roles in academic surgery. His research focuses on innovative therapies such as cold atmospheric plasma for cancer, wound healing, and oral diseases. He has authored impactful publications in high-ranking journals, with a strong emphasis on translational and interdisciplinary research. Awarded a summa cum laude for his medical doctorate, he is pursuing a second doctorate in dental medicine and a habilitation. Dr. Seebauer is actively involved in clinical trials, academic teaching, and scientific advising. His work reflects a commitment to advancing patient care through science, collaboration, and clinical excellence, making him a highly suitable candidate for prestigious research recognition such as the Best Researcher Award.

Professional Profile 

Google Scholar
Scopus Profile

Education

Dr. Christian Seebauer’s educational background reflects his exceptional commitment to interdisciplinary medical science. He earned his medical degree from Friedrich-Schiller-University Jena in 2006, graduating with high distinction and obtaining his medical license with a “very good” grade. Driven by an interest in craniofacial care, he pursued a second degree in dentistry at Ernst-Moritz-Arndt-University Greifswald, earning his dental license in 2015, again with top marks. He completed specialist training in Oral and Maxillofacial Surgery (2020) and Oral Surgery (2021), and is on track to receive an additional qualification in Plastic and Aesthetic Surgery by 2025. Academically, he achieved his Doctor of Medicine (summa cum laude) from Charité – Berlin in 2012, is completing a second doctorate in dental medicine, and is preparing his habilitation at University Medical Center Lübeck. His dual training uniquely equips him for complex surgical, academic, and translational roles in modern healthcare.

Professional Experience

Dr. Seebauer has accumulated extensive clinical and academic experience in leading German medical institutions. He began his residency in musculoskeletal surgery at Charité – Berlin (2007–2010), then transitioned into Oral and Maxillofacial Surgery at University Medical Centers in Jena and Greifswald. At Greifswald, he steadily advanced from resident to Specialist, then Senior Consultant, and eventually Managing Senior Consultant by 2023. In August 2024, he was appointed Senior Consultant at the University Medical Center Lübeck. Throughout his career, he has taken on multiple responsibilities beyond patient care, including roles in transfusion medicine, radiation safety, and medical coding. Dr. Seebauer is experienced in running clinical trials, mentoring young surgeons, and integrating advanced surgical techniques such as microvascular tissue transfer and plasma-based therapies. His professional trajectory demonstrates continuous growth in clinical leadership, academic excellence, and institutional trust, confirming his status as a respected authority in surgical and translational medicine.

Research Interest

Dr. Seebauer’s research centers on innovative, translational approaches to oral, mucosal, and dermal disease management, with a particular emphasis on cold atmospheric plasma. His work spans a range of high-impact medical themes, including wound healing, cancer therapy, precancerous lesions, chronic inflammation, and alternative cancer treatments. He has contributed significantly to both preclinical and clinical investigations, exploring how plasma technologies can improve outcomes in head and neck cancer, oral lichen planus, and leukoplakia. His recent studies include cohort analyses on the effects of anticoagulants on wound healing and the global impact of HPV vaccination on malignancy risks. He is actively involved in the planning of prospective, multicenter clinical trials and collaborates internationally via networks like TriNetX. His multidisciplinary approach combines surgery, oncology, immunology, and biomedical engineering, showcasing his ability to merge clinical insight with experimental innovation. These interests place him at the forefront of translational medical research in Europe.

Award and Honor

Dr. Christian Seebauer has earned several distinctions throughout his academic and clinical career. He was awarded his Doctor of Medicine degree summa cum laude, one of the highest academic honors in Germany, by the prestigious Charité – University Medical Center Berlin. His scientific work has been published in internationally renowned, peer-reviewed journals such as Radiology, Oral Diseases, and Pharmacological Research, some with impact factors exceeding 10. He has held trusted leadership roles, including Managing Senior Consultant, and serves as a Scientific Advisor to neoplas MED. His selection for these positions reflects institutional recognition of his scientific and clinical integrity. Although not explicitly listed, his rising trajectory in academic medicine and involvement in high-level research projects suggest a strong reputation within professional circles. His affiliations with organizations such as the National Center for Plasma Medicine and Rotary Club also highlight his commitment to service and excellence beyond his clinical duties.

Conclusion

Dr. Christian Seebauer exemplifies the ideal candidate for recognition as a Best Researcher. With dual qualifications in medicine and dentistry, a track record of clinical leadership, and a deep commitment to translational research, he bridges the gap between scientific discovery and patient care. His pioneering work in cold atmospheric plasma and its applications in oncology and regenerative medicine is both innovative and impactful, reflecting future-forward thinking in clinical science. His publication record, leadership roles, and collaborative involvement in global research initiatives further establish his credibility and influence in the medical community. Dr. Seebauer’s academic path—marked by excellence, versatility, and continual advancement—underscores his dedication to improving healthcare through research, education, and clinical innovation. As he continues his habilitation and leads new clinical trials, his contributions are poised to shape future standards in surgery and therapeutic technology. He is highly deserving of prestigious accolades such as the Best Researcher Award.

Publications Top Notes

  • Title: Clinical experience with cold plasma in the treatment of locally advanced head and neck cancer

    • Authors: HR Metelmann, C Seebauer, V Miller, A Fridman, G Bauer, DB Graves, …

    • Year: 2018

    • Citations: 353

  • Title: Head and neck cancer treatment and physical plasma

    • Authors: HR Metelmann, DS Nedrelow, C Seebauer, M Schuster, T von Woedtke, …

    • Year: 2015

    • Citations: 256

  • Title: Molecular mechanisms of the efficacy of cold atmospheric pressure plasma (CAP) in cancer treatment

    • Authors: ML Semmler, S Bekeschus, M Schäfer, T Bernhardt, T Fischer, K Witzke, …

    • Year: 2020

    • Citations: 216

  • Title: Comprehensive clinical plasma medicine: cold physical plasma for medical application

    • Authors: HR Metelmann, T Von Woedtke, KD Weltmann

    • Year: 2018

    • Citations: 162

  • Title: Visible tumor surface response to physical plasma and apoptotic cell kill in head and neck cancer

    • Authors: M Schuster, C Seebauer, R Rutkowski, A Hauschild, F Podmelle, …

    • Year: 2016

    • Citations: 152

  • Title: Cold atmospheric pressure plasma in wound healing and cancer treatment

    • Authors: L Boeckmann, M Schäfer, T Bernhardt, ML Semmler, O Jung, G Ojak, …

    • Year: 2020

    • Citations: 100

  • Title: Treating cancer with cold physical plasma: On the way to evidence‐based medicine

    • Authors: HR Metelmann, C Seebauer, R Rutkowski, M Schuster, S Bekeschus, …

    • Year: 2018

    • Citations: 65

  • Title: Hyperspectral imaging for in vivo monitoring of cold atmospheric plasma effects on microcirculation in treatment of head and neck cancer and wound healing

    • Authors: R Rutkowski, M Schuster, J Unger, C Seebauer, HR Metelmann, …

    • Year: 2017

    • Citations: 58

  • Title: Ankle laxity: stress investigation under MRI control

    • Authors: CJ Seebauer, HJ Bail, JC Rump, B Hamm, T Walter, UKM Teichgräber

    • Year: 2013

    • Citations: 55

  • Title: Side effects in cold plasma treatment of advanced oral cancer—Clinical data and biological interpretation

    • Authors: M Schuster, R Rutkowski, A Hauschild, RK Shojaei, T von Woedtke, …

    • Year: 2018

    • Citations: 48

  • Title: Physical plasma and leukocytes–immune or reactive?

    • Authors: S Bekeschus, C Seebauer, K Wende, A Schmidt

    • Year: 2018

    • Citations: 42

  • Title: Plasmamedizin

    • Authors: HR Metelmann, T von Woedtke, KD Weltmann

    • Year: 2016

    • Citations: 42

  • Title: Cold argon plasma as adjuvant tumour therapy on progressive head and neck cancer: A preclinical study

    • Authors: S Hasse, C Seebauer, K Wende, A Schmidt, HR Metelmann, …

    • Year: 2019

    • Citations: 41

  • Title: Third molars and periodontal damage of second molars in the general population

    • Authors: S Kindler, B Holtfreter, T Koppe, M Mksoud, C Lucas, C Seebauer, …

    • Year: 2018

    • Citations: 36

  • Title: Plasma-derived reactive species shape a differentiation profile in human monocytes

    • Authors: E Freund, J Moritz, M Stope, C Seebauer, A Schmidt, S Bekeschus

    • Year: 2019

    • Citations: 34

Vipul Wayal | Immunology and Microbiology| Excellence in Research Award

Published on by World Top Scientists

Dr. Vipul Wayal | Immunology and Microbiology| Excellence in Research Award

Postdoctoral Researcher at Tunghai University, Taiwan

Dr. Vipul Rohidas Wayal is a dynamic postdoctoral researcher specializing in biotechnology, translational medicine, and pharmaceutical sciences. Currently affiliated with Tunghai University in Taiwan, he has demonstrated exceptional expertise in bioactive peptides, metabolic diseases, and immunomodulation. His research has led to several high-impact publications and internationally recognized patents, reflecting strong innovation and translational potential. With a solid academic foundation—holding a Ph.D. in Animal Science and Biotechnology and a Master’s in Pharmaceutics—Dr. Wayal brings interdisciplinary proficiency across advanced bioinformatics, molecular docking, and animal modeling. He has actively contributed to projects targeting MAFLD, T2DM, and atherosclerosis and participated in global scientific forums such as BIO Asia and the Taiwan Innotech Expo. Recognized with scholarships and innovation awards, he is also skilled in scientific writing, grant proposals, and technology transfer. Dr. Wayal’s research impact and forward-thinking approach position him as a promising candidate for honors recognizing excellence in scientific research and innovation.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Dr. Vipul Rohidas Wayal has a robust academic background, reflecting a consistent focus on biomedical research and pharmaceutical sciences. He earned his Ph.D. in Animal Science and Biotechnology from Tunghai University, Taiwan, where his thesis explored the ameliorative effects of bioactive oligopeptides on metabolic-associated fatty liver disease (MAFLD) in murine models. His doctoral work integrated molecular biology, pharmacology, and biotechnology. Prior to this, he completed a Master of Pharmacy (M.Pharm) in Pharmaceutics from Rajiv Gandhi University of Health Sciences, Bangalore, India. His master’s thesis focused on the development of silk protein-based topical sprays for wound healing. Dr. Wayal also holds a Bachelor of Pharmacy from Savitribai Phule Pune University, India, where he conducted research on herbal gel formulations for wound healing. Throughout his education, he has cultivated expertise in drug delivery, biotechnology, and disease modeling, laying a solid foundation for translational research and pharmaceutical innovation.

Professional Experience

Dr. Wayal brings diverse professional experience, combining academic research with industrial roles. He currently serves as a postdoctoral researcher at Tunghai University, Taiwan, where he is involved in projects focusing on novel fermented foods, immunomodulators, and bioactive peptides for metabolic disorders such as NAFLD and T2DM. His earlier academic experience includes extensive work in molecular biology techniques, animal experimentation, and peptide-based therapeutic research. Before transitioning fully into academia, he held several positions in the pharmaceutical industry in India, including Factory Manager at Equine Nutrients and R&D Production Manager at Fibroheal Woundcare Pvt. Ltd., where he was involved in the development and manufacturing of wound-care products. Additionally, he worked as a Manufacturing Officer at Fresenius Kabi, handling large-scale pharmaceutical production. These roles have equipped him with hands-on expertise in technology transfer, quality control, and product development, giving him a practical perspective that complements his research endeavors.

Research Interest

Dr. Vipul Wayal’s research interests lie at the intersection of biotechnology, pharmaceutical sciences, and translational medicine. He is particularly focused on the discovery and functional evaluation of bioactive peptides and proteins for the prevention and treatment of metabolic diseases such as MAFLD, type 2 diabetes, and atherosclerosis. His work integrates molecular docking, bioinformatics, in vivo modeling, and immunological assays to uncover therapeutic pathways and mechanisms, particularly involving Nrf2/HO-1, TLR4/NF-κB, and inflammasome signaling. Additionally, he is involved in the development of functional foods with cardiovascular and immunomodulatory benefits. His broad skill set includes protein purification, ELISA, flow cytometry, and various forms of chromatography and spectroscopy, which support his bench-to-bedside research approach. Dr. Wayal also emphasizes innovative drug delivery systems, especially in peptide-based therapeutics, and is passionate about bridging the gap between laboratory discoveries and clinical applications through patentable, scalable solutions.

Award and Honor

Dr. Vipul Wayal has received recognition for both his academic performance and innovative research contributions. He was awarded the Tunghai University International Student Scholarship consecutively for the academic years 2021–2022 and 2022–2023, acknowledging his academic excellence and research productivity during his doctoral studies. One of his most notable achievements includes receiving the Excellent Idea Certificate for his patented innovation on “Novel Small Molecule Peptides for Anti-MAFLD Activity,” which has been granted in Taiwan and Japan and filed in the United States. His participation in international expos and conferences, such as the Taiwan Innotech Expo and BIO Asia–Taiwan, further emphasizes his growing international profile. These honors reflect his commitment to advancing science through novel and applicable innovations. While his accolades are notable, they also signal his potential for future recognition as his research continues to expand and influence both academic and applied biomedical fields.

Conclusion

In conclusion, Dr. Vipul Rohidas Wayal exemplifies a rising biomedical scientist with an impressive combination of academic excellence, industrial experience, and innovative research. His work in bioactive peptides, metabolic disease therapeutics, and functional food development has resulted in impactful publications and internationally recognized patents. He possesses a wide range of technical skills, from molecular biology to in silico modeling, supported by a solid educational foundation and cross-disciplinary collaborations. With experience spanning academia and pharmaceutical industries, Dr. Wayal effectively bridges fundamental research and real-world applications. His contributions demonstrate both scientific rigor and translational value, making him a strong contender for recognition such as the BExcellence in Research Award. As he continues to lead and contribute to projects addressing global health challenges, his trajectory indicates not only a promising research career but also the capacity to impact public health through innovation and scientific excellence.

Publications Top Notes

  • Title: Novel bioactive peptides alleviate Western diet-induced MAFLD…
    Authors: V. Wayal, S.D. Wang, C.C. Hsieh
    Journal: International Immunopharmacology 148
    Year: 2025
    Citations: 8

  • Title: Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced MAFLD…
    Authors: V. Wayal, C.C. Hsieh
    Journal: Biomedicine & Pharmacotherapy 168
    Year: 2023
    Citations: 7

  • Title: ASSESSMENT OF WOUND HEALING ACTIVITY OF POTENT HERBAL EXTRACTS GEL IN ALBINO WISTAR RAT
    Authors: V. Wayal, T.N.V.
    Journal: Asian Journal of Pharmaceutical and Clinical Research 15(08)
    Year: 2022
    Citations: 3

  • Title: Design, Development and Evaluation of Silk Based Film Forming Spray for Wound Healing
    Authors: V. Wayal, K. Nagasree, B.A. Vishwanath
    Journal: Journal of Drug Delivery & Therapeutics 11
    Year: 2021
    Citations: 3

  • Title: Chicken meat hydrolysate improves acetaminophen-induced liver injury…
    Authors: V. Wayal, Z.E. Tsai, Y.H. Lin, Y.H. Lai, S.D. Wang, C.C. Hsieh
    Journal: Journal of Agriculture and Food Research 21
    Year: 2025
    Citations: 1

  • Title: Immunomodulatory effects of type II arabinogalactans from Anoectochilus formosanus…
    Authors: Y.L. Huang, W.C. Lin, V. Wayal, C.C. Hsieh
    Journal: Carbohydrate Polymer Technologies and Applications
    Year: 2025

  • Title: Goat Whey Protein Hydrolysate Mitigates High-Fructose Corn Syrup-Induced Hepatic Steatosis…
    Authors: C.H. Shao, V. Wayal, C.C. Hsieh
    Journal: Preprints
    Year: 2025

  • Title: Type II Arabinogalactan from Anoectochilus Formosanus Dampens Allergic Airway Hyperresponsiveness…
    Authors: Y.L. Huang, V. Wayal, W.C. Lin, C.C. Hsieh
    Platform: SSRN Preprint
    Year: 2025

Stephen Higgins | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Stephen Higgins | Medicine and Dentistry | Best Researcher Award

Surgical Resident at Nebraska Medicine, United States

Dr. Stephen E. Higgins Jr., DMD, MPH, is an accomplished clinician and academician currently pursuing his M.D. at the University of Nebraska College of Medicine, with an expected graduation date of May 2025. He is a resident in Oral and Maxillofacial Surgery at the University of Nebraska Medical Center and Creighton University School of Dentistry. Dr. Higgins combines extensive training in dentistry, medicine, and public health to provide interdisciplinary insights into surgical and public health challenges. Known for his academic rigor and leadership, he serves as a Clinical Instructor at Creighton University and actively contributes to academic and clinical teaching. His commitment to excellence is reflected in his numerous presentations, scholarly publications, and leadership roles within national medical and dental organizations. Dr. Higgins is especially noted for his dynamic involvement in both clinical care and scientific research, aiming to integrate cutting-edge research with clinical practice. With more than a decade of progressive academic and research experience, Dr. Higgins stands out as a dedicated scholar, committed to improving patient care and advancing medical knowledge. His work reflects a balance of clinical expertise, teaching, and research that positions him as a future leader in oral and maxillofacial surgery.

Professional Profile

Education

Dr. Higgins has pursued a diverse and intensive academic path, integrating dentistry, medicine, and public health. He earned his Doctor of Dental Medicine (D.M.D.) degree from the University of New England College of Dental Medicine in 2022, where he also received multiple commendations for academic excellence and leadership. He holds a Master of Public Health (M.P.H.) from the University of Massachusetts Amherst, completed in 2018, where he developed a strong foundation in epidemiology, biostatistics, and health systems research. He is currently a candidate for a Doctor of Medicine (M.D.) degree at the University of Nebraska College of Medicine, scheduled to graduate in 2025. His academic journey began with a Bachelor of Science in Biology from Providence College in 2012, complemented by a minor in Business Studies. Dr. Higgins also completed a post-baccalaureate program at Worcester State University, graduating in 2016. His academic foundation has been enhanced by strong performance and honors, such as his induction into Phi Kappa Phi Honor Society. This comprehensive educational background uniquely equips Dr. Higgins with an integrated approach to healthcare, enabling him to navigate clinical practice, academic research, and health policy with precision and insight.

Professional Experience

Dr. Higgins’s professional trajectory reflects a blend of clinical practice, academic instruction, and research leadership. Since 2022, he has been training as a resident in Oral and Maxillofacial Surgery at the University of Nebraska Medical Center and Creighton University School of Dentistry. His dual-role residency under esteemed mentors Dr. Valmont Desa and Dr. Terry Lanphier emphasizes complex surgical procedures and interdisciplinary collaboration. Concurrently, he has served as a Clinical Instructor at Creighton University, where he mentors dental students in clinical procedures, case management, and academic development. Prior to his residency, he held leadership positions as President of the Oral and Maxillofacial Surgery Club and Student Representative to the Research Committee at the University of New England. His clinical experience is further strengthened by licensure to practice dentistry in Nebraska, and affiliations with major national bodies including the ADA, AMA, and AAOMS. Throughout his training, Dr. Higgins has demonstrated a strong commitment to integrating patient care with academic inquiry, often taking lead roles in research projects and quality improvement initiatives. His professional experience demonstrates a commitment to excellence, mentorship, and continuous learning in both surgical and academic contexts.

Research Interests

Dr. Higgins has cultivated a broad and evolving portfolio of research interests that span clinical oral surgery, public health, and medical education. His primary research focus includes the evaluation of surgical techniques in oral and maxillofacial surgery, particularly in stability and outcomes following procedures like sagittal split osteotomies. He has explored topics ranging from dentist comfort in diagnosing oral pathology to the impact of antibiotics on gut microbiota, reflecting his interdisciplinary expertise. Dr. Higgins has co-authored multiple peer-reviewed publications and has presented extensively at national conferences, including the Society for Academic Emergency Medicine and the North American Congress of Clinical Toxicology. His early work in emergency medicine explored benchmarking scholarly productivity, while subsequent research examined substance abuse interventions via telemedicine and health referral systems. These interests underscore his commitment to bridging gaps between research, policy, and patient care. By integrating clinical practice with inquiry-driven research, Dr. Higgins aims to advance evidence-based approaches in surgery and healthcare delivery. He continues to develop research that is translational in nature, driven by real-world clinical challenges and guided by rigorous academic methodologies.

Awards and Honors

Dr. Higgins has received numerous awards and recognitions throughout his academic and professional career, underscoring his excellence in leadership, research, and academic performance. While pursuing his D.M.D. at the University of New England, he was awarded the prestigious AAOMS Dental Student Award, recognizing exceptional promise in oral and maxillofacial surgery. He consistently earned Letters of Commendation for four consecutive years, reflecting his high academic performance and dedication. He graduated with Honors Research Distinction, highlighting his scholarly contributions to oral health research. He also received a Student Leadership Certificate for his active engagement in student organizations and advocacy. During his earlier academic career, Dr. Higgins was inducted into the Phi Kappa Phi Honor Society at Worcester State University, a distinction reserved for students of the highest academic caliber. These accolades reflect not only Dr. Higgins’s intellectual aptitude but also his capacity for leadership, initiative, and service. His ongoing involvement with national professional organizations such as the ADA, AMA, and AAOMS further reflects his commitment to the highest standards of clinical practice and professional development. These honors validate Dr. Higgins’s standing as a promising figure in academic medicine and surgery.

Conclusion

Dr. Stephen E. Higgins Jr. is a highly promising and accomplished early-career researcher whose interdisciplinary background and active research involvement make him a strong candidate for the Best Researcher Award. His combination of clinical training, research leadership, and publication record reflects a deep commitment to advancing evidence-based practices in oral and maxillofacial surgery and public health.

While he is still building his publication portfolio and academic footprint, the trajectory and potential for impact are clearly evident. If the award committee values early-career excellence, breadth of contribution, and leadership, Dr. Higgins would be a very deserving recipient.

Publications Top Notes

  • Authors: Stephen E. Higgins Jr., Valmont Desa

  • Year: 2025

  • Title: Comparing the Infection Rates of Strut Versus Straight Plates in Sagittal Split Osteotomies

  • Journal: Journal of Oral and Maxillofacial Surgery

  • DOI: 10.1016/j.joms.2025.03.001

  • Citation: Higgins, S.E. Jr., & Desa, V. (2025). Comparing the infection rates of strut versus straight plates in sagittal split osteotomies. Journal of Oral and Maxillofacial Surgery. https://doi.org/10.1016/j.joms.2025.03.001

 

  • Authors: Edwin D. Boudreaux, Stephen E. Higgins Jr., Rebecca Reznik-Zellen, Bo Wang, Gregory Volturo

  • Year: 2019

  • Title: Scholarly Productivity and Impact: Developing a Quantifiable, Norm-Based Benchmarking Methodology for Academic Emergency Medicine

  • Journal: Academic Emergency Medicine, Volume 26, Issue 6, Pages 594–604

  • DOI: 10.1111/acem.13704

  • Citation: Boudreaux, E.D., Higgins, S.E., Reznik-Zellen, R., Wang, B., & Volturo, G. (2019). Scholarly productivity and impact: Developing a quantifiable, norm-based benchmarking methodology for academic emergency medicine. Academic Emergency Medicine, 26(6), 594–604. https://doi.org/10.1111/acem.13704